JMIR Cancer is a peer-reviewed english-language open-access journal published by JMIR Publications in Canada, operating under an open-access model since 2015. The journal covers Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens.
Authors are required to pay an article processing charge to publish in JMIR Cancer; refer to the journal's APC page for the current rate. A waiver policy is offered for eligible authors. Articles are released under the CC BY license (see other journals using this license).
To date, JMIR Cancer has published 622 articles. Articles are minted with DOIs through the prefix 10.2196.
Keywords
cancer, oncology, informatics
At a glance
- Publisher
- JMIR Publications
- Country
- Canada
- Primary language
- English
- License
- CC BY
- Peer review
- Anonymous peer review
- OA since
- 2015
- Review time
- 18 weeks
- DOI prefix
10.2196
ISSN
- electronic
- 2369-1999
Frequently asked questions
Is JMIR Cancer peer-reviewed?
Yes — JMIR Cancer operates a Anonymous peer review review process.
Does JMIR Cancer charge an article processing charge (APC)?
Yes — refer to the journal's APC page for the current rate. A waiver policy is available for eligible authors.
What subjects does JMIR Cancer publish?
JMIR Cancer publishes research in Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens.
What languages does JMIR Cancer accept?
JMIR Cancer accepts manuscripts in English.
What is the ISSN of JMIR Cancer?
ISSN:
2369-1999 (electronic).How do I submit a manuscript to JMIR Cancer?
Submit through the journal's official portal: visit submission page →
How long does peer review take at JMIR Cancer?
Average time from submission to publication is approximately 18 weeks.